CLOS
PROK icon

Compagnie Lombard Odier SCmA’s ProKidney PROK Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,500
Closed -$72K – 680
2022
Q4 		$72K Hold
10,500
– – ﹤0.01% 432
2022
Q3 		$95K Buy
+10,500
New +$91.4K ﹤0.01% 393

Other funds holding PROK

SCG
Social Capital Group Menlo Park, California $5.16M AUM 66.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Compagnie Lombard Odier SCmA's PROK Position: Q1 2023 in Review

Compagnie Lombard Odier SCmA sold out of ProKidney (PROK) in Q1 2023, closing a stake of 10,500 shares — an estimated $72K sold.

Compagnie Lombard Odier SCmA first reported a position in PROK in Q3 2022 and held it in 2 quarters. The position peaked at $95K in Q3 2022. 35 funds tracked by Wall St. Rank hold PROK as of Q1 2023.

  • Compagnie Lombard Odier SCmA reported no remaining ProKidney position as of Q1 2023 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 10,500 ProKidney shares in Q1 2023, an estimated $72K.
  • Compagnie Lombard Odier SCmA first reported a position in ProKidney in Q3 2022 and held it in 2 quarters.
  • Compagnie Lombard Odier SCmA's ProKidney position peaked at $95K in Q3 2022.
  • 35 funds tracked by Wall St. Rank held ProKidney as of Q1 2023.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2023, filed 1 May 2023.